The result confirms that the combination therapy promotes the apoptosis of chondrosarcoma, which is attributed to the radiosensitization effect of celastrol by downregulating the expression of c-myc and inducing the G2/M phase arrest and the induction of chondrosarcoma apoptosis through the mitochondrial signaling pathway. The gene discussed is MYC; the disease is chondrosarcoma.